Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Language
Year range
1.
Rev. Inst. Med. Trop. Säo Paulo ; 41(4): 255-8, July-Aug. 1999. tab
Article in English | LILACS | ID: lil-246836

ABSTRACT

Outbred male albino mice normal or infected with 30 cercariae of Schistosoma mansoni (LE strain) were submitted to 65 percent hepatectomy during the acute (70 days) and chronic phase (160 days) phases of the disease. A group of the infected animals was treated with 400 mg/kg of oxamniquine during the acute phase before hepatectomy. Non-infected, infected and treated but not hepatectomized animals were kept as controls. Hepatic regeneration was evaluated by incorporation of tritiated thymidine, intraperitoneally injected into non-hepatectomized and hepatectomized animals, 24 hours after surgery. The results showed that removal of 65 percent of the hepatic parenchyma, during the acute phase, led to a statistically significant increase of thymidine incorporation, when compared with the uninfected hepatectomized controls. This phenomenon was not observed at the chronic phase. Treatment with oxamniquine administered during the acute phase led to a decrease in thymidine incorporation rate 160 days after infection (90 days after treatment) and 24 hours after hepatectomy. The data suggest that infection with S. mansoni represents a considerable stimulus for the regenerative capacity of the liver during the acute, but not the chronic phase of disease


Subject(s)
Mice , Animals , Male , Hepatectomy , Liver Regeneration , Oxamniquine/therapeutic use , Schistosoma mansoni , Schistosomiasis mansoni/drug therapy , Acute Disease , Chronic Disease , Schistosomiasis mansoni/chemically induced , Thymidine/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL